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Along an individual lifetime, stem cells replicate and suffer modifications in their DNA content.
I model the modifications in the DNA of a single cell as a Levy flight, made up of small amplitude
Brownian motions plus rare large-jumps events. The distribution function of mutations has a long
tail, in which cancer events are located far away. The probability of cancer in a given tissue is
roughly estimated as aNcellNstep, where Ncell is the number of stem cells, and Nstep – the number
of replication steps in the evolution of a single cell. I test this expression against recent data on
lifetime cancer risk, Ncell and Nstep in different tissues. The coefficient a takes values between
2 × 10−15 and 2 × 10−11, depending on the role played by carcinogenic factors and the immune
response. The smallest values of a correspond to cancers in which randomness plays the major role.
PACS numbers: 87.19.xj, 05.40.Fb, 87.23.Kg
Spontaneous vs induced mutations. A common
knowledge states that both the normal activity of stem
cells in a healthy individual, and external agents such
as ionizing or ultraviolet radiation, toxic substances (de-
rived from smoking, for example), etc cause mutations
[1]. Mutations related to the normal function of the cell
are called spontaneous. They are thought to have a ran-
dom origin, External agents, on their side, are visualized
as causes of induced mutations.
The debate about spontaneous (random) and induced
mutations and their role in carcinogenesis rose recently
[2–10] with the article [2], in which data on lifetime risk
of cancer in different tissues, along with the number of
stem cells, Ncell, and the number of replication steps,
Nstep, are compiled.
The purpose of my paper is to present a model for
mutations in stem cells and the genesis of cancer. Em-
phasis is put on the qualitative aspects. Detailed numer-
ical simulations for different tissues are to be published
elsewhere.
The accumulative character of mutations. Au-
thors of Ref. [2] postulate that the probability of a given
mutation (they are interested in cancer) should depend
on the overall number of replication steps in the tissue.
This assumption neglects the history in the evolution of
each cell.
In my model, on the contrary, the time evolution of
cells defines trajectories, as schematically represented in
Fig. 1, where one of these trajectories is drawn as a red
dashed line.
The idea about trajectories in the evolution of cells
means that there are Markov chains [11]) of mutations,
where the change in the DNA of a cell at step i + 1,
xi+1, comes from the change in the previous step plus an
additional modification:
xi+1 = xi + δ (1)
Measuring changes in the DNA A single strand
of human DNA contains around 3 × 109 bases of a four
letter alphabet: G, A, T, and C. [1]) In order to measure
FIG. 1. (Color online) Schematic representation of the evolu-
tion of stem cells in a tissue. First, the cells divide until their
number reaches Ncell. There are N
e
step ≈ log2Ncell steps in
this clonal expansion phase. Further on, the number of cells is
kept roughly constant. This means that the excess stem cells
resulting from divisions go to replace damaged cells in the tis-
sue or to a programmed apoptosis. If there are Nhstep steps in
this homeostasis phase, then the total number of replication
steps along a trajectory is Nstep = N
e
step +N
h
step.
changes in the DNA, one may use a variable similar to
that one of paper [12]).
First, define an auxiliary variable at site α in the
molecule: uα(G) = 3/8, uα(A) = 1/8, uα(T ) = −1/8,
and uα(C) = −3/8. Then, define a walk along the DNA:
y(β) =
β∑
α=1
uα. (2)
As a function of β, the variable y draws a profile of
the DNA molecule, and modifications can be measured
as: X(β) = y(β) − y0(β). where y correspond to the
mutated DNA, and y0 – to the initial configuration. Of
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2course, there are so many X(β), three billions, that they
are not of practical use. The strategy could be to restrict
the analysis to certain coding regions in the DNA, for ex-
ample, and for these regions, to use variables measuring
global changes or distances to the original function:
X =
L∑
α=1
(u′α − uα), (3)
X(1) =
L∑
α=1
α(u′α − uα), (4)
X(2) (the second moment), etc. L is the length of the
coding region. The Shannon informational entropy [13])
could also be of use.
In what follows, I shall assume that mutations in a
given coding region are well characterized by a few global
variables.
Other heritable gene variations, not involving changes
in the DNA sequence [14], could, in principle, be incor-
porated, although presently I do not have a proposal for
a variable measuring them.
Modeling mutations The δ term in Eq. (1) rep-
resents mutations at step i + 1. It may come from a
partially repaired damage in the DNA that is fixed after
replication, or from an undesired error in the replication
process. It should be stressed that both the repair mech-
anisms and the replication process guarantee very high
fidelities. The error introduced by the latter, for exam-
ple, is around one mistaken base per 109 bases in the
DNA strand [1]).
FIG. 2. (Color online) Schematic representation of a single
cell mutation trajectory. The starting point is X = 0. In the
mutation space, I distinguished regions in which the DNA
repair mechanism is active or damaged. The latter is one of
the hallmarks of cancer, known as genetic instability [15].
Let me stress, once again, that δ is not the damage
caused by endogenous or external factors, but the re-
sulting modification after the action of the repair mech-
anisms, and fixation. It is known, for example, that ion-
izing radiation may cause double strand breaks in the
DNA [16]. These damages are very difficult to repair
[1]). The repair mechanism itself may introduce large
changes in the resulting DNA composition after a double
strand break event.
My proposal for δ is the following: δ = δB + δLJ . The
δB component corresponds to a Brownian motion with
maximal amplitudeDB . Notice thatDB = 1 would mean
roughly a change of basis in each replication step because
uα(G)−uα(C) = 3/4. This Brownian motion introduces
local modifications in the DNA. After Nstep replication
steps, the characteristic dispersion of a trajectory due to
this Brownian motion (something like the radius of the
colored region near the origin in Fig. 2) is DB
√
Nstep.
[17]
The large-jump component of δ, δLJ , on the other
hand, is modeled with the help of rare events with total
probability p << 1, and a probability density propor-
tional to 1/δ2LJ , where the amplitude ranges from DB to
infinity (in practice, I will introduce a cutoff, Dmax). The
combination of the Brownian motion and the large am-
plitude jumps leads to Levy flights [18]) in the mutation
space, schematically represented in Fig. 2.
Let me notice that the distribution function associated
to Levy flights is a fat- or long-tail one. This fact could
be related to the long range correlations observed in the
walks along the DNA [12].
The long-tail distribution function of muta-
tions. Four parameters enter my oversimplified Levy
model of mutations in stem cells: Ncell, Nstep, DB and
p. In order to fix ideas, I show a calculation with pa-
rameters that, although arbitrary, approximately fit the
data on lifetime risk of cancer in the gallbladder tissue.
The result, however, will be not only the probability of
cancer, but the distribution function of mutations of any
amplitude.
I took Nestep = 20, which corresponds to Ncell ≈ 106.
On the other hand, Nhstep = 47, as in Ref. [2], thus
Nstep = 67.
I restrict the analysis to a coding region in the DNA of
length L = 106. Around 10−3 basis are changed in each
replication step, thus I take DB = 10
−3. Cancer events
are assumed to be at a distance Xcancer >> DB
√
Nstep
from the origin. It is fixed to Xcancer = 1000. The
probability p = 3.8× 10−5 was chosen in order to fit the
lifetime risk of gallbladder cancer [2, 19].
Simulations start from a single cell. After Nestep di-
vision steps, the Ncell trajectories are generated. These
trajectories proceed Nhstep steps further. In any replica-
tion step, either of the expansion or homeostasis phase,
mutations are given by Eq. (1), where δ contains both
the Brownian and the large-amplitude components.
The probability distribution function for mutations in
a cell, P (X), is the probability that a cell arrives at the
end point with an amplitude X. I compute not P (X),
but the cumulative probability distribution, P (|X| > Z),
which is shown in Fig. 3.
The Brownian radius,
√
Nstep DB ∼ 8×10−3, concen-
trating most of the points, is apparent in the figure. In
3FIG. 3. (Color online) The average cumulative probabil-
ity of mutations, P (|X| > Z), in a coding segment of the
DNA molecule. Points come from the numerical simulations,
whereas the red solid line is a 1/Z fit to the tail. The Brownian
radius, DB
√
Nstep, is marked by a dashed line. Parameters
are chosen in order that the slope in the tail reproduces the
lifetime risk for cancer in the gallbladder tissue.
addition, the tail can be fitted to a 1/Z dependence. The
coefficient is roughly NstepDB p.
Notice that the probability of cancer in the tissue can
be estimated as Ncell P (|X| > Xcancer). As Xcancer is in
the tail of the distribution, we may use the asymptotic
formula:
risk ≈ NcellNstepDB p/Xcancer = aNcellNstep. (5)
For the gallbladder example, a ≈ 2.5 × 10−11. Be-
cause a ∼ DB p/Xcancer, there is an arbitrariness in the
selection of the parameters DB , p and Xcancer. How-
ever, it should be possible to select or pick up a unique
meaningful set consistent with this numerical value. The
asymptotic formula, Eq. (5), does not depend on the
choice of parameters.
Analysis of the data on cancer in different tis-
sues. I use Eq. (5) in order to re-examine the data
presented in paper [2]). The qualitative idea is the fol-
lowing: the lowest values of a correspond to tissues in
which mutations are close to the naturally occurring ones
in a healthy individual. On the contrary, high values of
a indicate the presence of strong abnormal conditions or
external factors in the genesis of cancer. In Fig. 4, I
show the results for the lifetime risk of cancer per stem
cell versus Nstep. This magnitude can be directly related
to the formulae of the previous sections. In order to fa-
cilitate the analysis, the studied cancers are divided in
groups.
Group I includes 11 points in the figure, located in a
band delimited by coefficients 2 × 10−14 < a < 10−13.
In the lack of a better name, I call this set the normal
group. I use a solid red line in order to distinguish the
bottom edge, and a dashed red line for the top one. In
this set, randomness seems to play an important role in
the genesis of cancer, as originally claimed in Ref. [2].
The fact that this group is composed by very different
tissues – from the medulloblastoma to the colorectal ade-
nocarcinoma – is, perhaps, the confirmation that, under
unperturbed conditions, tissues in the body evolve in a
very similar way. The starting point in the Levy model,
DB , p and Xcancer should take very similar values for all
of them.
For the coefficient a, we may write the expression:
a = ERS × 2× 10−14. (6)
The in-front factor, ERS, a kind of measure of the ef-
fects of lifestyle or external carcinogens, takes values be-
tween 1 and 5 (see Table I), meaning that, in principle, by
means of proper correctives, the risk for cancer could be
reduced, for example, around twice in the colorectal ade-
nocarcinoma, four times in the basal cell carcinoma, or
five times in the lung adenocarcinoma in the non-smoker
sub-population.
Group II, with five points in the figure, include cases in
which genetic or viral causes are predominant. Genetic
predisposition means that mutations start at a point
closer than usual to the cancer region. Thus, the distance
Xcancer is much shorter and the probability dramatically
increases. The ERS index exhibits very high values in
this set.
The abnormal values of ERS for the four cases con-
tained in Group III have, in my opinion, an immuno-
logical origin. Indeed, germinal cells and the brain are
partially isolated from the immune agents. Our body
uses barriers in order to protect these tissues against in-
fections, but the barriers can not protect against tumors,
which come from inside. From the point of view of can-
cer, they are immunodepressed tissues.
Thus, I may say that aprot ≈ 2 × 10−14 is a reference
value for a tissue protected by a normal immune system,
whereas adepr ≈ 2 × 10−12 (100 times higher) refers to
immunodepression conditions.
On the other hand, the extremely low value of a for the
small intestine adenocarcinoma (eight times lower than
normal) can not have other explanation than overpro-
tection by the immune system. One may speculate that
the small intestine is a possible entrance door for the mi-
crobiota living in the colon, and as such it requires spe-
cial protection. Paneth cells, Peyer’s patches, and other
structures concentrated in the distal ileum, are perhaps
the responsibles for this reinforced protection. This fact
should be further studied. If confirmed, one can even
imagine therapies against cancer or other illness exploit-
ing this extra capacity of the small intestine.
Finally, there is a group of 11 cancers (5 tissues) ex-
hibiting abnormally high values of the ERS index, pre-
sumably related to strong external factors. One exam-
ple is lung adenocarcinoma, for which the concurrence
of radioactive Radon and smoking produces a 90-fold in-
crease of the slope. The extreme case in this group is
4Cancer type ERS
Group I. Normal
Hepatocellular C 1.13
Melanoma 1.16
Pancreatic endocrine C 1.23
Pancreatic ductal AC 1.45
Medulloblastoma 1.49
Myeloid leukemia 1.54
Duodenal AC 1.93
Lymphocytic leukemia 1.95
Colorectal AC 2.04
Basal Cell C 4.02
Lung AC (non-smokers) 5.15
Group II. Viral and Genetic
Hepatocellular C with HCV 11.29
Colorectal AC with Lynch 21.30
Head and Neck SCC with HPV 122.96
Colorectal AC with FAP 204.51
Duodenal AC with FAP 225.29
Group III. Immune
Small intestinal AC 0.12
Glioblastoma 14.48
Testicular germinal cell 52.78
Ovarian germinal cell 79.86
Group IV. Abnormal
Head and Neck SCC 21.38
Osteosarcoma (Head) 70.02
Esophageal SCC 79.44
Thyroid medullary C 84.22
Lung AC (smokers) 92.77
Osteosarcoma (Arms) 124.72
Osteosarcoma (Pelvis) 138.08
Osteosarcomas 153.04
Thyroid papillary and follicular C 239.78
Osteosarcoma (Legs) 266.49
Gallbladder non papillary AC 1299.58
TABLE I. The Extra Risk Score (ERS) index of Eq. (6) for
cancer in different tissues.
gallbladder non-papillary adenocarcinoma, with an in-
dex ERS = 1300, the understanding of which is a real
challenge.
Mutations in bacteria. With appropriate parame-
ters, my Levy model can be applied as well to mutations
in bacteria. I recall the extremely interesting Long Time
Evolution Experiment with E. Coli, conduced by Prof.
R. Lenski and his group [20]. Besides many other re-
sults, they report frequencies at which a mutation with
damages in the DNA repair mechanisms becomes domi-
nant in a population [21]. This mutator phenotype has
in common with cancer, besides DNA instability, that it
should be far away in the tail of the probability distri-
bution. Thus, I may use Eq. (5) for the probability of
occurrence, and determine the coefficient a.
The number of cultures they use is small, 12. Thus,
I expect statistical errors of the order of 1/
√
12 ∼ 0.3
for the probability. Nevertheless, they report that the
mutator phenotype becomes dominant in two cultures
(cumulative probability 1/6) when Nstep ≈ 2500− 3000,
in a third culture (cumulative probability 1/4) when
Nstep ≈ 8500, and in a fourth culture (cumulative proba-
bility 1/3) when Nstep ≈ 15000. From this data and the
number of evolving trajectories, Ncell ≈ 5× 106, I obtain
abact ≈ 5 × 10−12. It is remarkable, that abact is of the
same order of magnitude of adepr. Details can be found
in Ref. [22].
Concluding remarks. In my model, stem cells draw
Levy flights in the mutation space. The small ampli-
tude Brownian component is characterized by a radius
DB
√
Nstep, whereas the rare large jumps give rise to a
long tail ∼ 1/Z in the cumulative probability distribu-
tion. Cancer events are located in the tail. Their rate
can be estimated from Eq. (5), where a ∼ DB p/Xcancer.
Variations in a are mainly related to variations in p, the
probability of nonlocal changes in the DNA. Trajectories
in the mutation space are always random, external car-
cinogens basically increase the probability p. The ERS
index defined in Eq. (6) has, thus, a clear meaning as a
reference to a normal tissue, unperturbed by external fac-
tors. Re-examination of the data reported in Ref. [2] re-
veals groups of cancers, which range from normal tissues
(randomness dominated cancers) to abnormal tissues, in
which external carcinogens play the major role. Particu-
larly interesting is the small intestine, which seems to be
overprotected by the immune system. My model stresses
the role of mutations in the genesis of cancer. It is rea-
sonable to expect, however, a formula like Eq. (5) to be
valid even when epigenetic or microenvironment factors
are taken into account [23].
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